Enzymes Market Report 2026

Enzymes Market Overview

• Enzymes market size has reached to $15.2 billion in 2025 • Expected to grow to $28.7 billion in 2030 at a compound annual growth rate (CAGR) of 13.5% • Growth Driver: Unlocking The Potential Of Enzyme-Based Therapies In The Global Fight Against Cancer • Market Trend: Innovative Enzyme-Based Medications Transforming Treatment For Rare Genetic Disorders • North America was the largest region in 2025.

What Is Covered Under Enzymes Market?

Enzyme refers to a protein that almost usually serves as a biological catalyst. It accelerates a certain chemical reaction in the cell. It is a substance that serves as a catalyst in living things, controlling the speed at which chemical processes take place without undergoing any changes. The main product types of enzymes are asparaginase, lipase, protease, nattokinase, chitinase, serratiopeptidase, collagenase, ligase, and others. A protease is an enzyme that catalyzes proteolysis, which breaks proteins down into smaller polypeptides or single amino acids and promotes the formation of new protein products. The enzymes are used for the treatment of leukemia, stomach disorders, antitumor, skin ulcers, gauche disease, Fabry disease, and others and are used by drug manufacturers, hospitals, private clinics, and research laboratories.

What Is The Enzymes Market Growth Forecast?

The enzymes market size is expected to see rapid growth in the next few years. It will grow to $28.7 billion in 2030 at a compound annual growth rate (CAGR) of 13.5%. The growth in the forecast period can be attributed to growth in personalized medicine, advances in protein engineering, rising demand for industrial enzymes in food and beverage, increasing focus on sustainable enzyme production, expansion of emerging markets in asia-pacific. Major trends in the forecast period include enzyme engineering and protein design, industrial enzyme applications expansion, personalized enzyme therapy, microbial enzyme innovation, green and sustainable enzyme production.

Global Enzymes Market Segmentation

1) By Product Type: Asparaginase, Lipase, Protease, Nattokinase, Chitinase, Serratiopeptidase, Collagenase, Ligase, Other Products 2) By Application: Leukemia, Stomach Disorders, Antitumor, Skin Ulcers, Gaucher Disease, Fabry Disease, Other Applications 3) By End User: Drug Manufacturers, Hospitals, Private Clinics, Research Laboratories Subsegments: 1) By Asparaginase: L-asparaginase, Erwinia Asparaginase, Pegylated Asparaginase 2) By Lipase: Gastric Lipase, Pancreatic Lipase, Fungal Lipase, Bacterial Lipase 3) By Protease: Serine Proteases, Cysteine Proteases, Aspartic Proteases, Metalloproteases 4) By Nattokinase: Nattokinase Powder, Nattokinase Capsules 5) By Chitinase: Plant Chitinase, Microbial Chitinase 6) By Serratiopeptidase: Serratiopeptidase Tablets, Serratiopeptidase Capsules 7) By Collagenase: Type I Collagenase, Type II Collagenase, Type III Collagenase 8) By Ligase: DNA Ligase, RNA Ligase 9) By Other Products: Amylase, Cellulase, Beta-Glucanase

What Is The Driver Of The Enzymes Market?

The growing prevalence of cancer requiring drug-metabolizing enzymes (DMEs) for chemotherapy is expected to drive the growth of the enzyme market in the coming years. The activation of enzymes in the human body help destroy the cancer cells and breaks down the tumor. The expression and function of drug-metabolizing enzymes (DMEs) in cancer patients' tumor tissues and metabolic organs is therefore essential and help patients for whom reaction to anticancer drugs and response to chemotherapy is low. For instance, in September 2025, according to the American Cancer Society, a US-based professional organization, in the United States, an estimated 313,780 new cases of prostate cancer are expected in 2025 and the risk of developing prostate cancer increases sharply with age, rising from 0.2% in men under 50 to 6.5% in those aged 70–79. Therefore, the increasing prevalence of cancer that can be cured using therapeutic enzymes is predicted to drive the enzyme industry growth.

Key Players In The Global Enzymes Market

Major companies operating in the enzymes market are Novozymes A/S, DuPont Industrial Biosciences, BASF SE, Koninklijke DSM N.V., Chr. Hansen Holding A/S, Roche Holding AG, Advanced Enzyme Technologies Ltd., AB Enzymes GmbH, Codexis Inc., Dyadic International Inc., Amano Enzyme Inc., Adisseo France SAS, Biocatalysts Ltd., Amano Enzyme Inc., Enzyme Development Corporation, Creative Enzymes, Hayashibara Co. Ltd., Thermo Fisher Scientific Inc., Associated British Foods Plc, Lonza Group AG, Novus International Inc., Epygen Biotech, DSM Nutritional Products AG, Soufflet Biotechnologies SAS, Beijing Leili Marine Bioindustry Inc., Jiangsu Boli Bioproducts Co. Ltd.

Global Enzymes Market Trends and Insights

Major companies operating in the enzyme market are developing innovative products such as Lamzede to better serve patients. Lamzede (velmanase alfa) is a medication used for the treatment of alpha-mannosidosis, a rare genetic disorder caused by deficient activity of the lysosomal alpha-galactosidase-A enzyme. For instance, in May 2023, Chiesi Global Rare Diseases, a US-based pharmaceutical manufacturing company received FDA approval for Lamzede (velmanase alfa) for the treatment of non-neurological symptoms of patients with mild-to-moderate alpha-mannosidosis. Lamzede is a recombinant form of human alpha-mannosidase developed in mammalian Chinese hamster ovary (CHO) cells using recombinant DNA technology. It is the first enzyme replacement therapy approved in the U.S. for the treatment of the non-central nervous system manifestations of alpha-mannosidosis.

What Are Latest Mergers And Acquisitions In The Enzymes Market?

In February 2023, AstraZeneca, a US-based pharmaceutical company acquired CinCor Pharma Inc. for $1.3 billion. The acquisition will bolster AstraZeneca’s cardiorenal pipeline by adding CinCor’s candidate drug, baxdrostat (CIN-107), an aldosterone synthase inhibitor (ASI) for blood pressure lowering in treatment-resistant hypertension. CinCor Pharma Inc. is a US-based biotechnology company developing enzyme-based therapeutics.

Regional Insights

North America was the largest region in the enzymes market in 2025. The regions covered in this market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in this market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

What Defines the Enzymes Market?

The enzyme market consists of sales of oxidoreductases, transferases, and hydrolases. Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

How is Market Value Defined and Measured?

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified). The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

What Key Data and Analysis Are Included in the Enzymes Market Report 2026?

The enzymes market research report is one of a series of new reports from The Business Research Company that provides market statistics, including industry global market size, regional shares, competitors with the market share, detailed market segments, market trends and opportunities, and any further data you may need to thrive in the enzymes industry. The market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future state of the industry.